Keratinocytes in skin inflammation

References

• Vocanson M, Hennino A, Chavagnac C et al. Contribution of CD4+ and CD8+ T-cells in contact hypersensitivity and allergic contact dermatitis.Expert Rev. Clin. Immunol.1(1), 75–86 (2005).
   PubMedGoogle Scholar
• Grabbe S, Steinert M, Mahnke K, Schwarz A, Luger TA, Schwarz T. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis.J. Clin. Invest.98(5), 1158–1164 (1996).
   PubMed Web of Science ®Google Scholar
• Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G. Keratinocytes in inflammatory skin diseases.Curr. Drug Targets Inflamm. Allergy4(3), 329–334 (2005).
   PubMedGoogle Scholar
• Pastore S, Cavani A, Albanesi C, Girolomoni G. Chemokines of human skin. In:Skin Immune System. Cutaneous Immunology and Clinical Immunodermatology. JD Bos (Ed.). CRC Press, Boca Raton, FL, USA,373–392 (2005).
   Google Scholar
• Albanesi C, Scarponi C, CavaniA, Federici M, Nasorri F, Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4-induced activation of human keratinocytes.J. Invest. Dermatol.115(1), 81–87 (2000).
   PubMed Web of Science ®Google Scholar
• Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.J. Exp. Med.192(7), 1027–1034 (2000).
   PubMed Web of Science ®Google Scholar
• Pastore S, Fanales-Belasio E, Albanesi C, Chinni ML, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.J. Clin. Invest.99(12), 3009–3017 (1997).
   PubMed Web of Science ®Google Scholar
• Ohta Y, Hamada Y, Katsuoka K. Expression of IL-18 in psoriasis.Arch. Dermatol. Res.293(7), 334–342 (2001).
   PubMed Web of Science ®Google Scholar
• Companjen A, van der Wel L, van der Fits L, Laman J, Prens E. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.Eur. Cytokine Net.15(3), 210–216 (2004).
   PubMed Web of Science ®Google Scholar
• Konishi H, Tsutsui H, Murakami T et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions.Proc. Natl Acad. Sci. USA 99(17), 11340–11345 (2002).
   PubMed Web of Science ®Google Scholar
• Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses.Ann Rev. Immunol.19, 423–474, (2001).
   PubMed Web of Science ®Google Scholar
• Albanesi C, Scarponi C, Sebastiani S et al. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.J. Immunol.165(3), 1395–1402 (2000).
   PubMed Web of Science ®Google Scholar
• Girolomoni G, Sebastiani S, Albanesi C, Cavani A. T-cell subpopulations in the development of atopic and contact allergy.Curr. Opin. Immunol.13(6), 733–737 (2001).
   PubMed Web of Science ®Google Scholar
• Albanesi C, Scarponi C, Sebastiani S et al. A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases.J. Leukoc. Biol.70(4), 617–623 (2001).
   PubMedGoogle Scholar
• Dorschner RA, Lopez-Garcia B, Massie J, Kim C, Gallo RL. Innate immune defence of the nail unit by anti-microbial peptides.J. Am. Acad. Dermatol.50(3), 343–348 (2004).
   PubMedGoogle Scholar
• Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human β-defensin 3, a novel human inducible peptide antibiotic.J. Biol. Chem.276(8), 5707–5713 (2001).
   PubMed Web of Science ®Google Scholar
• Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus.J. Invest. Dermatol.117(1), 91–97 (2001).
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis.N. Engl. J. Med.347(15), 1151–1160 (2002).
   PubMed Web of Science ®Google Scholar
• Nomura I, Goleva E, Howell MD et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response.J. Immunol.171(6), 3262–3269 (2003).
   PubMed Web of Science ®Google Scholar
• Howell MD, Novak N, Bieber T et al. Interleukin-10 down-regulates anti-microbial peptide expression in atopic dermatitis.J. Invest. Dermatol.125(4), 738–745 (2005).
   PubMed Web of Science ®Google Scholar
• McInturff JE, Modlin RL, Kim J. The role of Toll-like receptors in the pathogenesis and treatment of dermatological disease.J. Invest. Dermatol.125(1), 1–8 (2005).
   PubMed Web of Science ®Google Scholar
• Kollisch G, Kalali BN, Voelcker V et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.Immunology114(4), 531–541 (2005).
   PubMed Web of Science ®Google Scholar
• Sørensen OE, Cowland JB, Theilgaard-Mönch K, Liu L, Ganz T, Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors.J. Immunol.170(11), 5583–5589 (2003).
   PubMed Web of Science ®Google Scholar
• Miller LS, Sørensen OE, Liu PT et al. TGF-α regulates TLR expression and function on epidermal keratinocytes.J. Immunol.174(10), 6137–6143 (2005).
   PubMed Web of Science ®Google Scholar
• Pastore S, Mascia F, Mariotti F, Dattilo C, Girolomoni G. Chemokine networks in inflammatory skin diseases.Eur. J. Dermatol.14(4), 203–208 (2004).
   PubMed Web of Science ®Google Scholar
• Engelhardt E., Toksoy A, Goebeler M, Debus S, Brocker EB, Gillitzer R. Chemokines IL-8, Gro-α, MCP-1, IP-10, and MIG are sequentially and differentially expressed during phase-specific infiltration of leukocyte subset in human wound healing.Am. J. Pathol.153(6), 1849–1860 (1998).
   PubMed Web of Science ®Google Scholar
• Goebeler M, Trautmann A, Voss A, Brocker E, Toksoy A, Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity.Am. J. Pathol.158(2), 431–440 (2001).
   PubMed Web of Science ®Google Scholar
• Homey B, Alenius H, Muller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.Nature Med.8(2), 157–165 (2002).
   PubMed Web of Science ®Google Scholar
• Mascia F, Mariani V, Girolomoni G, Pastore S. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.Am. J. Pathol.163(1), 303–312 (2003).
   PubMed Web of Science ®Google Scholar
• Pastore S, Mascia F, Dattilo C, Mariani V, Girolomoni G. ERK1/2 regulates epidermal chemokine expression and skin inflammation.J. Immunol.174(8), 5047–5056 (2005).
   PubMed Web of Science ®Google Scholar
• Schön MP, Boehncke WH. Psoriasis.N. Engl. J. Med.352(18), 1899–1912 (2005).
   PubMed Web of Science ®Google Scholar
• Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis.Nature Rev. Immunol.5(9), 699–711 (2005).
   PubMed Web of Science ®Google Scholar
• Iizuka H, Takahashi H, Honma M, Ishida-Yamamoto A. Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death.J. Dermatol.31(4), 271–276 (2004).
   PubMedGoogle Scholar
• Nickoloff BJ, Ben-Neriah Y, Pikarsky E. Inflammation and cancer: is the link as simple as we think?J. Invest. Dermatol.124(6), x–xiv (2005).
   PubMedGoogle Scholar
• Villadsen LS, Schuurman J, Beurskens F et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.J. Clin. Invest.112(10), 1571–1580 (2003).
   PubMed Web of Science ®Google Scholar
• Ruckert R, Asadullah K, Seifert M et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?J. Immunol.165(4), 2240–2250 (2000).
   PubMed Web of Science ®Google Scholar
• Piskin G, Silva-Steenland RM, Bos JD, Teunissen BM. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.J. Immunol.176(3), 1908–1915 (2006).
   PubMed Web of Science ®Google Scholar
• Giustizieri ML, Mascia F, Frezzolini A et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.J. Allergy Clin. Immunol.107(5), 871–877 (2001).
   PubMed Web of Science ®Google Scholar
• Giustizieri ML, Albanesi C, Scarponi C, De Pità O, Girolomoni G. Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo.Am. J. Pathol.161(4), 1409–1418 (2002).
   PubMedGoogle Scholar
• Homey B, Dieu-Nosjean MC, Wiesenborn A et al. Up-regulation of macrophage inflammatory protein 3α/CCL20 and CC chemokine receptor 6 in psoriasis.J. Immunol.164(12), 6621–6632, 2000.
   PubMedGoogle Scholar
• Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin αEβ7 in the pathogenesis of psoriasis vulgaris.Lab. Invest.81(3), 335–347 (2001).
   PubMed Web of Science ®Google Scholar
• Vanbervliet B, Homey B, Durand I et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces.Eur. J. Immunol.32(1), 231–242 (2002).
   PubMedGoogle Scholar
• Hudak S, Hagen M, Liu Y et al. Immune surveillance and effector functions of CCR10 (+) skin homing T cells.J. Immunol.169(3), 1189–1196 (2002).
   PubMed Web of Science ®Google Scholar
• Nomura I, Gao B, Boguniewicz, Darst MA, Travers JB, Leung DYM. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis.J. Allergy Clin. Immunol.112(6), 1195–1202 (2003).
   PubMed Web of Science ®Google Scholar
• Fraticelli P, Sironi M, Bianchi G et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.J. Clin. Invest.107(9), 1173–1181 (2001).
   PubMed Web of Science ®Google Scholar
• McKenzie RC, Sabin E. Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis.Exp. Dermatol.12(4), 337–345 (2003).
   PubMed Web of Science ®Google Scholar
• Bruch-Gerharz D, Schnorr O, Suschek C et al. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.Am. J. Pathol.162(1), 203–211 (2003).
   PubMed Web of Science ®Google Scholar
• Namazi MR. Explaining decreased nitric oxide production in psoriatic lesions: arginase 1 overexpression versus calcitonin gene-related peptide.Am. J. Pathol.163(6), 2642–2643 (2003).
   PubMedGoogle Scholar
• Asadullah K, Sabat R, Friedrich M, Volk HD, Sterry W. Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis.Curr. Drug Targets Inflamm. Allergy3(2), 195–182 (2004).
   Google Scholar
• Mrowietz U, Asadullah K. Dimethylfumarate for psoriasis: more than a dietary curiosity.Trends Mol. Med.11(1), 43–48 (2005).
   PubMed Web of Science ®Google Scholar
• Asadullah K, Friedrich M, Hanneken S et al. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings.J. Invest. Dermatol.116(5), 721–727 (2001).
   PubMed Web of Science ®Google Scholar
• Reich K, Garbe C, Blaschke V et al. Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, down-regulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation.J. Invest. Dermatol.116(2), 319–329 (2001).
   PubMed Web of Science ®Google Scholar
• Stoof TJ, Flier J, Sampat S, Nieboer C, Tensen CP, Boorsma DM. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells.Br. J. Dermatol.144(6), 1114–1120 (2001).
   PubMed Web of Science ®Google Scholar
• Girolomoni G, Pastore S. Epithelial cells and atopic diseases.Curr. Allergy Asthma Rep.1(6), 481–482 (2001).
   PubMedGoogle Scholar
• Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis.J. Clin. Invest.113(5), 651–657 (2004).
   PubMed Web of Science ®Google Scholar
• Sicherer SH, Leung DYM. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects.J. Allergy Clin. Immunol.116(1), 153–163 (2005).
   PubMedGoogle Scholar
• Elias PM. Stratum corneum defensive functions: an integrated view.J. Invest. Dermatol.125(2), 183–200 (2005).
   PubMed Web of Science ®Google Scholar
• Klunker S, Trautmann A, Akdis M et al. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-γ-inducible protein 10, monokine induced by IFN-γ, and IFN-γ-inducible α-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis.J. Immunol.171(2), 1078–1084 (2003).
   PubMed Web of Science ®Google Scholar
• Hatano Y, Terashi H, Arakawa S, Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by TNF-α and IFN-γ in human epidermis.J. Invest. Dermatol.124(4), 786–792 (2005).
   PubMed Web of Science ®Google Scholar
• Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G. H1 histamine receptor mediates inflammatory responses in human keratinocytes.J. Allergy Clin. Immunol.114(5), 176–182 (2004).
   Google Scholar
• Gunther C, Bello-Fernandez C, Kopp T et al. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells.J. Immunol.174(3), 1723–1728 (2005).
   PubMed Web of Science ®Google Scholar
• Pivarcsi A, Gompert M, Dieu-Nosjean MC et al. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure.J. Immunol.173(9), 5810–5817 (2004).
   Google Scholar
• Schmuth M, Neyer S, Rainer C et al. Expression of the C-C chemokine MIP-3α/CCL20 in human epidermis with impaired permeability barrier function.Exp. Dermatol.11(2), 135–142 (2002).
   PubMedGoogle Scholar
• Reich K, Hugo S, Middel P et al. Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitis.J. Allergy Clin. Immunol.109(4), 681–687 (2002).
   PubMedGoogle Scholar
• Reich K, Heine H, Hugo S et al. Engagement of the FcεRI stimulates the production of IL-16 in atopic dermatitis.J. Immunol.167(11), 6321–6329 (2001).
   PubMedGoogle Scholar
• D’Ambrosio D, Albanesi A, Lang R, Girolomoni G, Sinigaglia F, Laudanna C. Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion.J. Immunol.169(5), 2303–2312 (2002).
   PubMed Web of Science ®Google Scholar
• Hijnen D, Bruin-Weller M, Oosting B et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.J. Allergy Clin. Immunol.113(2), 334–340 (2004).
   PubMed Web of Science ®Google Scholar
• Gombert M, Dieu-Nosjean MC, Winterberg F et al. CCL1–CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.J. Immunol.174(8), 5082–5091 (2005).
   PubMed Web of Science ®Google Scholar
• Echigo T, Hasegawa M, Shimada Y, Takehara K, Sato S. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.J. Allergy Clin. Immunol.113(5), 940–948 (2004).
   PubMedGoogle Scholar
• Pastore S, Giustizieri M, Mascia F, Giannetti A, Kaushansky K, Girolomoni G. Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor.J. Invest. Dermatol.115(6), 1134–1143 (2000).
   PubMedGoogle Scholar
• Girolomoni G, Mascia F, Dattilo C, Giannetti A, Pastore S. Keratinocytes in atopic eczema. In:Handbook of Atopic Eczema. Ring J, Przybilla B, Ruzicka T (Eds). Springer-Verlag, Berlin, Germany,332–339 (2006).
   Google Scholar
• Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.Nat. Immunol.3(7), 673–680 (2002).
   PubMed Web of Science ®Google Scholar
• Gilliet M, Soumelis V, Watanabe N et al. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells.J. Exp. Med.197(8), 1059–1063 (2003).
   PubMed Web of Science ®Google Scholar
• Yoo J, Omori M, Gyarmati D et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin.J. Exp. Med.202(4), 541–549 (2005).
   PubMed Web of Science ®Google Scholar
• Kozma GT, Falus A, Bojszko A et al. Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1.Allergy57(2), 160–163 (2002).
   PubMed Web of Science ®Google Scholar
• Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium.Nature Rev. Immunol.4(12), 978–988 (2004).
   PubMed Web of Science ®Google Scholar
• Yamazaki F, Aragane Y, Maeda A et al. Overactivation of IL-4-induced activator protein-1 in atopic dermatitis.J. Dermatol. Sci.28(3), 227–233 (2002).
   PubMedGoogle Scholar
• Jones MJ, Murray AW. Evidence that ceramide selectively inhibits protein kinase C-α translocation and modulates bradykinin activation of phospholipase D.J. Biol. Chem.270(10), 5007–5013 (2003).
   Google Scholar
• Nguyen C, Teo JL, Matsuda A et al. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma.Proc. Natl Acad. Sci. USA100(3), 1169–1173 (2003).
   PubMedGoogle Scholar
• Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin.Nature Rev. Mol. Cell Biol.6(4), 328–340 (2005).
   PubMed Web of Science ®Google Scholar
• Zeeuwen PLJM. Epidermal differentiation: the role of proteases and their inhibitors.Eur. J. Cell Biol.83(11–12), 761–773 (2004).
   PubMedGoogle Scholar
• Mägert H-J, Drögemüller K, Raghunath M. Serine proteinase inhibitors in the skin: role in homeostasis and disease.Curr. Protein Pept. Sci.6(3), 241–254 (2005).
   PubMed Web of Science ®Google Scholar
• Hansson L, Backman A, Ny A et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis.J. Invest. Dermatol.118(3), 444–449 (2002).
   PubMed Web of Science ®Google Scholar
• Vasilopoulos Y, Cork MJ, Murphy R et al. Genetic association between an AACC insertion in the 3´ UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis.J. Invest. Dermatol.123(1), 62–66 (2004).
   PubMed Web of Science ®Google Scholar
• Hachem JP, Man MQ, Crumrine D et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity.J. Invest. Dermatol.125(4), 510–520 (2005).
   PubMed Web of Science ®Google Scholar
• Bitoun E, Chavanas S, Irvine AD et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families.J. Invest. Dermatol.118(2), 352–361 (2002).
   PubMed Web of Science ®Google Scholar
• Descargues P, Deraison C, Bonnart C et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity.Nature Genet.37(1), 56–65 (2005).
   PubMed Web of Science ®Google Scholar
• Ishida-Yamamoto A, Deraison C, Bonnart C et al. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.J. Invest. Dermatol.124(2), 360–366 (2005).
   PubMed Web of Science ®Google Scholar
• Walley AJ, Chavanas S, Moffatt MF et al. Gene polymorphism in Netherton and common atopic disease.Nature Genet.29(2), 175–178 (2001).
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Buddenkotte J, Shpacovitch V et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.Endocrinol. Rev.26(1), 1–43 (2005).
   PubMed Web of Science ®Google Scholar
• Crivellato E, Ribatti D. Involvement of mast cells in angiogenesis and chronic inflammation.Curr. Drug Targets Inflamm. Allergy4(1), 9–11 (2005).
   PubMedGoogle Scholar
• Weidinger S, Rümmler L, Klopp N et al. Association study of mast cell chymase polymorphisms with atopy.Allergy60(10), 1256–1261 (2005).
   PubMed Web of Science ®Google Scholar
• Igney FH, Asadullah K, Zollner TM. Techniques: species’ finest blend – humanized mouse models in inflammatory skin disease research.Trends Pharmacol. Sci.25(1), 543–549 (2004).
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis.Am. J. Pathol.155(1), 145–158 (1999).
   PubMed Web of Science ®Google Scholar
• Biedermann T, Schwarzler T, Lametschwandtner G et al. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo.Eur. J. Immunol.32(11), 3171–3180 (2002).
   PubMed Web of Science ®Google Scholar
• Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis.Blood102(1), 161–168 (2003).
   PubMed Web of Science ®Google Scholar
• Li AG, Wang D, Feng XH, Wang XJ. Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder.EMBO J.23(8), 1770–1781 (2004).
   PubMed Web of Science ®Google Scholar
• Sano S, Chan KS, Carbajal S et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.Nature Med.11(1), 43–49 (2005).
   PubMed Web of Science ®Google Scholar
• Zenz R, Eferl R, Kenner L et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.Nature437(7057), 369–375 (2005).
   PubMed Web of Science ®Google Scholar